The MPTP story

JW Langston - Journal of Parkinson's disease, 2017 - journals.sagepub.com
The identification of MPTP, a relatively simple compound which causes selective
degeneration of the substantia nigra after systemic administration, has had an a significant …

Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside

A Mishra, R Bandopadhyay, PK Singh, PS Mishra… - Metabolic Brain …, 2021 - Springer
Neuroinflammation is one of the host defensive mechanisms through which the nervous
system protects itself from pathogenic and or infectious insults. Moreover, neuroinflammation …

Glial reactions in Parkinson's disease

PL McGeer, EG McGeer - Movement disorders: official journal …, 2008 - Wiley Online Library
Dopaminergic neurons of the substantia nigra are particularly vulnerable to oxidative and
inflammatory attack. Such processes may play a crucial role in the etiology of Parkinson …

Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy

L Qian, PM Flood, JS Hong - Journal of neural transmission, 2010 - Springer
Parkinson's disease (PD) is a neurodegenerative movement disorder characterized by the
progressive loss of dopaminergic neurons in the substantia nigra and depletion of dopamine …

Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease

L Zecca, H Wilms, S Geick, JH Claasen… - Acta …, 2008 - Springer
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by a
selective loss of dopaminergic neurons in the substantia nigra (SN). It has been suggested …

Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions

F Zhang, JS Shi, H Zhou, B Wilson, JS Hong… - Molecular …, 2010 - Elsevier
Parkinson's disease (PD) is the second most common neurodegenerative disease
characterized by a progressive loss of dopamine (DA) neurons in the substantia nigra …

Oxidative stress and microglial cells in Parkinson′ s disease

LJ Peterson, PM Flood - Mediators of inflammation, 2012 - Wiley Online Library
Significant evidence has now been accumulated that microglial cells play a central role in
the degeneration of DA neurons in animal models of PD. The oxidative stress response by …

Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders

L Nguyen, KL Thomas, BP Lucke-Wold… - Pharmacology & …, 2016 - Elsevier
Dextromethorphan (DM) is a commonly used antitussive and is currently the only FDA-
approved pharmaceutical treatment for pseudobulbar affect. Its safety profile and diverse …

RETRACTED: Icariin Reduces Dopaminergic Neuronal Loss and Microglia-Mediated Inflammation in Vivo and in Vitro

GQ Wang, DD Li, C Huang, DS Lu, C Zhang… - Frontiers in Molecular …, 2018 - frontiersin.org
Parkinson's disease (PD) is one of the most common neurodegenerative diseases
characterized with a gradual loss of midbrain substantia nigra (SN) dopamine (DA) neurons …

Fluoxetine protects neurons against microglial activation-mediated neurotoxicity

F Zhang, H Zhou, BC Wilson, JS Shi, JS Hong… - Parkinsonism & related …, 2012 - Elsevier
Neuroinflammation is closely associated with the pathogenesis of Parkinson's disease (PD)
and other neurological disorders. Increasing evidence suggests that inhibition of microglia …